. Author manuscript; available in PMC: 2022 Jul 1.

Published in final edited form as: Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 Jul 3;6(7):735–744. doi: 10.1016/j.bpsc.2020.06.015

Table 2:

Clinical Measures for patients at baseline (TP1); 24 hours after the first infusion (TP2) and 24–72 hours after fourth infusion (TP3).

	TP1	TP2	TP3	ANOVA
	Mean (SD)	Mean (SD)	Mean (SD)	F	p
HDRS	19.3 (5.2)	13.0 (4.6)	8.3 (4.2)	57.8	<0.0001
Rumination	13.0 (3.1)	11.7 (3.2)	10.3 (2.2)	9.4	<0.0001
BIS	23.8 (3.2)	23.0 (4.0)	22.5 (3.4)	1.3	0.27
SHAPS	7.7 (4.0)	6.4 (4.4)	3.2 (3.7)	13.4	<0.0001
DASS	5.1 (4.7)	3.7 (3.7)	1.6 (2.0)	9.2	<0.0001

HDRS: Hamilton Depression Rating Scale- 17 item, BIS: behavioral inhibition scale, SHAPS: Snaith-Hamilton Pleasure Scale, DASS: Depression Anxiety Stress Scale